Nelma Cristina D. Clementino

Author

Hospital das Clínicas da Universidade Federal de Minas Gerais

Also Known As

Nelma Cristina D Clementino, Nelma Cristina D. Clementino, Nelma Cristina Diogo Clementino

Publications

426

Citations

H-Index

Concepts

All Affiliations

Hospital das Clínicas da Universidade Federal de Minas Gerais The University of Adelaide South Australian Health and Medical Research Institute Novartis (France)Princess Margaret Cancer Centre

About

Nelma Cristina D. Clementino is an author at Hospital das Clínicas da Universidade Federal de Minas Gerais specializing in hematology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	122
2	Health Sciences	2	2	57
3	Public Health	1	1	34
4	Allergy	1	1	31
5	Diagnostic Sciences	1	1	13

Nelma Cristina D. Clementino

Publications

377

Citations

H-Index

Page 1

	Year	Citations
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase François-Xavier Mahon, Carla Boquimpani, Dong‐Wook Kim, Annals of Internal Medicine	2018	127
Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib Timothy P. Hughes, Jeffrey H. Lipton, Nelson Spector, Blood	2014	96
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update Timothy P. Hughes, Nelma Cristina D. Clementino, Mikhail Fominykh, Leukemia Hematological MalignancyChronic Myeloid LeukemiaOncologyMixed-phenotype Acute LeukemiaHematology	2021	44
De novo acute myeloid leukemia in adults younger than 60 years of age: Socioeconomic aspects and treatment results in a Brazilian university center Evandro M. Fagundes, Vanderson Rocha, Ana Glória, Leukemia & lymphoma/Leukemia and lymphoma Family MedicineMixed-phenotype Acute LeukemiaEpidemiology Of CancerCancer DisparityBrazilian University Center	2006	34
research paper: <i>IL1RN</i> VNTR and <i>IL2</i>−330 polymorphic genes are independently associated with chronic immune thrombocytopenia Andréia Maria Camargos Rocha, Cláudia Souza, Gifone Aguiar Rocha, British Journal of Haematology GeneticsImmunodeficienciesImmunologyImmune RegulationGenetic Epidemiology	2010	31
Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop Timothy P. Hughes, Carla Boquimpani, Naoto Takahashi, Blood	2016	21
Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study. Timothy P. Hughes, Carla Boquimpani, Dong‐Wook Kim, Journal of Clinical Oncology ImmunologyPharmacotherapyMyeloid NeoplasiaHematological MalignancyEnestop Study	2016	13
Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase François‐Xavier Mahon, Carla Boquimpani, Naoto Takahashi, Blood	2016	11

Page 1